[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

India Stem Cell Banking Market Studied in In-Demand Report by Kuick Research

15 May 2013 • by Natalie Aster

One of the most lucrative destinations for medical tourism, India has added stem cell banking as the latest weapon in its armamentarium. Many factors are actively contributing towards this overwhelming success and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge.

Cryopreservation is usually carried out at international storage facilities of their Indian counterparts, since the investment needs are huge to setup such laboratories, especially with less revenue generation. More so, foreign counterparts have the expertise to handle such sample so that their potency is not lost. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters.

According to the report “India Stem Cell Banking Market Analysis” by Kuick Research, stem cell banking has not yet been a revenue generating industry for any of the players so far. Huge investments are needed to setup these repositories where the short term returns are minimal. Increase in procedural costs might further degrade the growth and such is not the preferred means of earning back. However, proper counseling and increased awareness can definitely leads to increase in number of people undergoing stem cell banking thereby increasing the returns.

Report Details:

India Stem Cell Banking Market Analysis
Published: April, 2013
Pages: 55
Price: US$ 500.00

There might an increase in the number of stem cell banks in India in the recent future and this can be attributed to the factors enlisted below:

  • Of the key players in the country, it is estimated that many private players would like to have a widespread network and percolate to rural areas to make their presence felt. 
  • India is the world’s largest birthing country and expectations are highest offers genetic versatility and base for conducting most of the clinical trials. 
  • Analysts expect aggressive marketing and increasing prosperity signaled by penetration rates that could go beyond 1 per cent signifying ten-fold growth. 
  • The investment though seems huge as a onetime spent, but the stored cord blood cells can be preserved for xx years and costs around Rs 70,000-80,000, which is an insignificant spent. The advantages offered however, are huge keeping in mind that they can be used to treat diseases either for the same person or for a relative or person with a matching cell profile. This basic understanding of the concept and the financial burden has forced many couples to seek such measure to ensure a long term healthy life for their progeny in an era where new diseases mushroom every other day. 
  • Further keeping in mind the financial pinch, many private players have introduced the scheme of EMI scheme during the economic lows to make it significantly more affordable. 
  • Fuelling these banks is the global research in stem cell therapies, thereby creating a need for having the cord blood cells and stem cells in menstrual blood preserved. Greater the success of these stem cells in curing those diseases which till date have been incurable by other means of treatment more is the need of these preservation clinics.

More information can be found in the report “India Stem Cell Banking Market Analysis” by Kuick Research.

To order the report or ask for sample pages contact [email protected]


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest